Category Archives: Biopharma

Specialty Pharmacy News Roundup: December 2023

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends

hATTR-PN Drug WAINUA™ Available at Orsini Specialty Pharmacy

WAINUA™ for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis is available at Orsini Specialty Pharmacy

Biologics by McKesson and Onco360 Selected as Specialty Pharmacy Partners for Fruzaqla, Ogsiveo, and Truqap

Biologics by McKesson and Onco360 Selected as Specialty Pharmacy Partners for Fruzaqla, Ogsiveo, and Truqap

Specialty Pharmacy News Roundup: November 2023

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends

Ardelyx Sets Specialty Pharmacy Limited Distribution Network for XPHOZAH®

AMI’s Specialty Pharmacy Database includes the list of limited distribution partners for hundreds of specialty pharmaceuticals as well as additional comprehensive information on 1,600 specialty pharmacies

Celltrion Healthcare Contracts with CarePartners Pharmacy for Yuflyma

Celltrion Healthcare recently signed an agreement with Libertyville, IL-based CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the U.S. market

Specialty Pharmaceutical Hub Services News Roundup: July 2023

AMI’s annual Specialty Hub Service Providers Report provides comprehensive business intelligence on more than 70 companies

Employer Plans View Product Coverage Very Differently from PBMs

Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies